Business Context and Reporting Period
This Form 8-K Current Report was filed by SANUWAVE Health, Inc. on January 10, 2025, covering events occurring on January 3, 2025, and January 6, 2025. The filing addresses executive leadership changes within the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Departure of Executive: On January 3, 2025, Timothy Hendricks separated from service as Executive Vice President of Sales, effective immediately.
- Appointment of Executive: On January 6, 2025, Timothy Wern was appointed as the new Executive Vice President of Sales.
Management Commentary and Risks
Management highlighted Mr. Wern's extensive background in healthcare sales, including leadership roles at HeartWare International, Abiomed, and Ceevra. His expertise includes team building, funnel management, and launching medical devices in U.S. and Canadian markets. Regarding the departure of Mr. Hendricks, the Company noted that terms of a separation agreement are currently being negotiated and are expected to be finalized at a later date. No specific financial risks or contingencies were disclosed in this filing.
Investor Verification Checklist
- Verify the final terms of the separation agreement with Timothy Hendricks once finalized.
- Monitor future filings for any financial impact related to the executive transition.
- Review the Company's sales pipeline and strategy under the new leadership of Timothy Wern.